Hahn Brian M.
SEC CIK 1589711 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CBIO | CRESCENT BIOPHARMA, INC. | CFO, SVP Fin | 70.6K | $25.6K | $10.4K | 4 | 2022-03-09 | 2024-06-18 |
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Hahn Brian M. made no open-market trades at CBIO in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-20 | 2024-06-18 | CBIO | CRESCENT BIOPHARMA, INC. | Hahn Brian M. | CFO, SVP Fin | P - Purchase | $0.25 | +17.5K | 70.6K | +33% | +$4,375 | |
| 2023-05-18 | 2023-05-17 | CBIO | CRESCENT BIOPHARMA, INC. | Hahn Brian M. | CFO, SVP Fin | S - Sale | $1.95 | -3,700 | 53.1K | -7% | -$7,215 | |
| 2022-11-14 | 2022-11-11 | CBIO | CRESCENT BIOPHARMA, INC. | Hahn Brian M. | CFO, SVP Fin | P - Purchase | $1.06 | +20.0K | 56.8K | +54% | +$21.2K | |
| 2022-03-10 | 2022-03-09 | CBIO | CRESCENT BIOPHARMA, INC. | Hahn Brian M. | CFO, SVP Fin | S - Sale | $1.09 | -2,917 | 36.8K | -7% | -$3,180 |
Purchase Sale Sale after option exercise All abbreviations